I suffer from a rare genetic condition called Ehlers Danlos Syndrome. I struggled in high school due to hospitalizations nearly all of my sophomore and junior year, and I was placed on the homebound program my school district offers for students with chronic and life-threatening illnesses. It was incredibly isolating due to the program restricting its participants from any extracurricular activity, which hindered my ability to experience research or medical programs my peers did, as well as my social and mental health. I used this experience as an opportunity for growth rather than a burden, and I became the first student to ever complete AP classes successfully as a homebound student. I learned perseverance, dedication, and self-motivation as well as strengthening my desire to learn through hardship.
I used my experience to inspire others and I spoke at a board of education meeting over the inequitable policies of the homebound program, pushing my school district to facilitate change as it gained over 60,000 views on social media. It sparked a movement in my district and other students found the courage to speak in front of the board like I did over other issues concerning racial discrimination, accessibility, sexual assault, and LGBTQ rights. I issued a proclamation in my city naming May Ehlers Danlos Syndrome Awareness Month. I also work to raise awareness about being disabled in higher education, and I am working on opening a chapter of Students for RARE at my university to combat the stigma around disability, raise awareness, and provide a place for disabled students to share experiences and get help for accessibility issues they may face.
I plan on pursuing a career in research and to get a PhD in Biophysics. I worked my spring freshman year as a Clinical Research Assistant for the DICE study, working with underserved children with type 1 diabetes to improve health literacy. This past summer, I was a RADIANCE Scholar at Washington University School of Medicine where I worked in the Sah Lab studying small molecule inhibitors of the SWELL1 channel, an anion channel involved in cardiovascular and metabolic function, strokes, and type 1 diabetes. I tested several small molecule inhibitors for potential drug use and I am currently a co-author on a publication in review. I will present my research at the Biophysical Society's Annual Meeting in 2025. This summer, I learned that I didn't need to become a Physician to make a difference. While my disability prevents me from becoming a Physician, I am able to contribute to improving the quality of life of others with rare conditions like mine by researching novel treatments, medical devices, and drugs. The RADIANCE program was designed for underrepresented minorities in biomedical research, and for the first time I was treated like an equal rather than a burden because of my disability. I recently joined the Chakrapani lab at my university, now studying glycine receptors and their involvement in pain. I am using the technique of electrophysiology I learned this summer to improve patients' treatment options for pain. I will use my PhD to improve access to healthcare for underserved communities and patients with rare conditions with a lack of options.